These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17189262)

  • 1. Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation.
    Qin Z; Hu D; Han S; Reaney SH; Di Monte DA; Fink AL
    J Biol Chem; 2007 Feb; 282(8):5862-70. PubMed ID: 17189262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in secondary structure of α-synuclein during oligomerization induced by reactive aldehydes.
    Cai Y; Lendel C; Österlund L; Kasrayan A; Lannfelt L; Ingelsson M; Nikolajeff F; Karlsson M; Bergström J
    Biochem Biophys Res Commun; 2015 Aug; 464(1):336-41. PubMed ID: 26129771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.
    Xiang W; Schlachetzki JC; Helling S; Bussmann JC; Berlinghof M; Schäffer TE; Marcus K; Winkler J; Klucken J; Becker CM
    Mol Cell Neurosci; 2013 May; 54():71-83. PubMed ID: 23369945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molar excess of 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote oligomerization of alpha-synuclein through different pathways.
    Almandoz-Gil L; Welander H; Ihse E; Khoonsari PE; Musunuri S; Lendel C; Sigvardson J; Karlsson M; Ingelsson M; Kultima K; Bergström J
    Free Radic Biol Med; 2017 Sep; 110():421-431. PubMed ID: 28690195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of α-synuclein.
    Bae EJ; Ho DH; Park E; Jung JW; Cho K; Hong JH; Lee HJ; Kim KP; Lee SJ
    Antioxid Redox Signal; 2013 Mar; 18(7):770-83. PubMed ID: 22867050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties.
    Näsström T; Fagerqvist T; Barbu M; Karlsson M; Nikolajeff F; Kasrayan A; Ekberg M; Lannfelt L; Ingelsson M; Bergström J
    Free Radic Biol Med; 2011 Feb; 50(3):428-37. PubMed ID: 21130160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid vesicles affect the aggregation of 4-hydroxy-2-nonenal-modified α-synuclein oligomers.
    Sardar Sinha M; Villamil Giraldo AM; Öllinger K; Hallbeck M; Civitelli L
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3060-3068. PubMed ID: 29960040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid Peroxidation Products HNE and ONE Promote and Stabilize Alpha-Synuclein Oligomers by Chemical Modifications.
    Andersen C; Grønnemose AL; Pedersen JN; Nowak JS; Christiansen G; Nielsen J; Mulder FAA; Otzen DE; Jørgensen TJD
    Biochemistry; 2021 Nov; 60(47):3644-3658. PubMed ID: 34730940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders.
    Di Domenico F; Tramutola A; Butterfield DA
    Free Radic Biol Med; 2017 Oct; 111():253-261. PubMed ID: 27789292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL).
    Follmer C; Coelho-Cerqueira E; Yatabe-Franco DY; Araujo GD; Pinheiro AS; Domont GB; Eliezer D
    J Biol Chem; 2015 Nov; 290(46):27660-79. PubMed ID: 26381411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein.
    Hong DP; Fink AL; Uversky VN
    J Mol Biol; 2008 Oct; 383(1):214-23. PubMed ID: 18775438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers.
    Vaikath N; Sudhakaran I; Abdi I; Gupta V; Majbour N; Ghanem S; Abdesselem H; Vekrellis K; El-Agnaf O
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity.
    Xiang W; Menges S; Schlachetzki JC; Meixner H; Hoffmann AC; Schlötzer-Schrehardt U; Becker CM; Winkler J; Klucken J
    Mol Neurodegener; 2015 Mar; 10():8. PubMed ID: 25886189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two conformationally distinct α-synuclein oligomers share common epitopes and the ability to impair long-term potentiation.
    van Diggelen F; Hrle D; Apetri M; Christiansen G; Rammes G; Tepper A; Otzen DE
    PLoS One; 2019; 14(3):e0213663. PubMed ID: 30901378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lipid peroxidation metabolite 4-oxo-2-nonenal cross-links alpha-synuclein causing rapid formation of stable oligomers.
    Näsström T; Wahlberg T; Karlsson M; Nikolajeff F; Lannfelt L; Ingelsson M; Bergström J
    Biochem Biophys Res Commun; 2009 Jan; 378(4):872-6. PubMed ID: 19070597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and Characterization of Stable α-Synuclein Oligomers.
    Almandoz-Gil L; Ingelsson M; Bergström J
    Methods Mol Biol; 2018; 1779():61-71. PubMed ID: 29886527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine oxidation in α-synuclein inhibits its propensity for ordered secondary structure.
    Ponzini E; De Palma A; Cerboni L; Natalello A; Rossi R; Moons R; Konijnenberg A; Narkiewicz J; Legname G; Sobott F; Mauri P; Santambrogio C; Grandori R
    J Biol Chem; 2019 Apr; 294(14):5657-5665. PubMed ID: 30755483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic effects of dopamine metabolism in Parkinson's disease.
    Hattoria N; Wanga M; Taka H; Fujimura T; Yoritaka A; Kubo S; Mochizuki H
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S35-8. PubMed ID: 19131041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.
    Singh P; Bhat R
    ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction with phospholipids modulates alpha-synuclein nitration and lipid-protein adduct formation.
    Trostchansky A; Lind S; Hodara R; Oe T; Blair IA; Ischiropoulos H; Rubbo H; Souza JM
    Biochem J; 2006 Jan; 393(Pt 1):343-9. PubMed ID: 16146428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.